GLP-1 Pill Shows Benefit in Sleep Apnea
MedPage Today · 1d ago
Orforglipron
Medicine & Biotech · covered by 12 outlets this week · tracked since 2026-10-27
Press: 4 mainstream 9 specialist 1 independent outlet-days
Background
Orforglipron, sold under the brand name Foundayo, is a medication used for weight management. It is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
Medical Xpress · 1d ago
peer-reviewedtrtranslation pending
Zayıflama İlacı Orforglipron Obstrüktif Uyku Apnesinin Şiddetini Azaltmada Etkili Bulundu: JAMA'da Yayımlanan Araştırma Ne Gösteriyor?
Sağlık Aktüel · 1d ago
Orforglipron Cuts Sleep Apnea Burden by About Half
ConscienHealth · 1d ago
Weight-Loss Drugs May Help Sleep Apnea and Arthritis
Time Health · 2d ago
Oral GLP-1 reduces sleep apnea severity, cardiometabolic risk
Healio · 2d ago
review
A review of different brands of orforglipron (appetite suppressant
Reddit r/Biohackers · 6d ago
study
In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than dapagliflozin at 40 wk
Annals of Internal Medicine · 8d ago
Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages
Healthline · 15d ago
A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts
Cardiovascular Business · 37d ago